Blog

Asthma is one of the most common chronic health diseases that affects over 260 million people worldwide and is responsible for over 450,000 deaths each year across the globe. Most of these deaths are preventable with access to recommended treatments.  What is Asthma?  Asthma is a common lung condition that causes mild breathing difficulties. It […]

Tuberculosis (TB) affects millions of people worldwide, highlighting the urgent need for ongoing research. Clinical trials are vital in expanding our understanding of the disease and advancing more effective treatments. With TB cases increasing in recent years, the role of clinical research has never been more critical in the fight against this global health threat.With […]

Clinical trials remain crucial to further developing our understanding of Cystic Fibrosis and how it can be treated, as there is no cure for the disease. In 2007, screening newborn babies using the Newborn blood spot test was made mandatory. Implementing such measures further emphasises how scientists and medical specialists agree on the importance of […]

At Simbec-Orion, we bring nearly 50 years of experience as a Clinical Research Organisation focused on oncology and rare diseases. What is Respiratory Syncytial Virus (RSV)? Respiratory syncytial virus (RSV) infects lungs and airways leading to coughs and colds. In most cases it will clear after a few weeks, but can become serious in young […]

Clinical trials are essential in advancing treatments for skin cancer, a disease that has been on the rise in recent years. As the 17th most common cancer globally, it impacts millions of people each year, making continued research vital.  With nearly 50 years of expertise in managing clinical trials across all phases of development—from early […]

As awareness of rare diseases has grown, significant investment has been made to improve the processes and systems to support correct diagnosis and patient care. However, many of these initiatives are focused on a national level, which can create unintentional barriers for clinical research. Rare disease studies require a patient-centric approach and are often designed around the needs (and locations) of patients living with the disease. This Rare Disease Day, we take a brief look at what recent developments have been made into rare disease clinical research, and what we may be able to learn from them.

Lupus is a chronic autoimmune disease that affects millions worldwide, with 1 in 1000 people in the UK diagnosed. As the flare-ups can be unpredictable and impact one or multiple organs, innovative and advancing treatments are key. Clinical trials are highly important for those with lupus, because despite medical professionals understanding the disease more, treatments […]